Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday?
2025-04-15 05:40
https://finance.yahoo.com/news/why-viking-therapeutics-inc-vktx-044028854.html?.tsrc=rss

[<p class="tertiary yf-iko9m3 centerText">Oops, something went wrong</p>, <p class="modules-module_tipMessage__ZQFev">Tip: Try a valid symbol or a specific company name for relevant results</p>, <p class="tertiary yf-iko9m3 centerText">Oops, something went wrong</p>, <p class="notification-list-item-body yf-9621vi">Trump's trade war is unlikely to bring tech manufacturing back to the US anytime soon. Here's why.</p>, <p class="notification-list-item-body yf-9621vi">Dow slides 700 points, Nasdaq leads market rout as Powell warns of 'challenging' tariff impact</p>, <p class="notification-list-item-body yf-9621vi">The Nasdaq was down over 4% as a tech-led sell-off intensified in late-afternoon trading</p>, <p class="notification-list-item-body yf-9621vi">The major indexes sank to session lows as Fed Chair Powell warned of stagflationary impacts from President Trump's tariffs.</p>, <p class="notification-list-item-body yf-9621vi">Powell sees 'challenging scenario' for Fed if Trump tariffs stoke inflation and slow growth</p>, <p class="notification-list-item-body yf-9621vi">The Nasdaq fell over 2%, leading the way down as Nvidia found itself caught in the crossfire of the US-China trade war.</p>, <p class="notification-list-item-body yf-9621vi">The Treasury secretary told us he thinks America's biggest CEOs should stop worrying about the economy. Here's why.</p>, <p class="notification-list-item-body yf-9621vi">The chipmaker's stock took a hit after it revealed the Trump administration's surprise new controls on exports to China.</p>, <p class="notification-list-item-body yf-9621vi">Stocks resume slide as Nvidia weighs on tech</p>, <p class="notification-list-item-body yf-9621vi">Retail sales surged in March at the biggest rate in over two years, in what was the latest sign of the US economy's pre-tariff strength.</p>, <p class="notification-list-item-body yf-9621vi">Why your water bill is an inflation problem that isn't budging</p>, <p class="notification-list-item-body yf-9621vi">Stock market today: Dow, S&amp;P 500, Nasdaq futures fall as Nvidia reveals costly limits on China exports</p>, <p class="notification-list-item-body yf-9621vi">The Treasury secretary told Yahoo Finance that the next 90 days should provide 'substantial clarity' on tariffs</p>, <p class="notification-list-item-body yf-9621vi">Treasury Secretary Scott Bessent tells Yahoo Finance that the US has a 'big toolkit' to deal with bond market volatility</p>, <p class="notification-list-item-body yf-9621vi">Stocks drift lower as tariff chaos pauses for a day</p>, <p class="notification-list-item-body yf-9621vi">The chip giant committed to building AI infrastructure in the US, and Trump says he's going to help make it happen.</p>, <p class="notification-list-item-body yf-9621vi">The fallout from Trump's tariff whiplash hasn't yet pushed investors to shy away from an old habit</p>, <p class="notification-list-item-body yf-9621vi">Stocks edge higher after back-to-back rallies with Trump's latest tariff moves in focus</p>, <p class="notification-list-item-body yf-9621vi">BofA's Moynihan says 'we potentially face a changing economy' after highest-ever equities trading haul</p>, <p class="notification-list-item-body yf-9621vi">The trade war uncovers new economies of scale</p>, <p class="notification-list-item-body yf-9621vi">Trump is wrecking his own economic agenda</p>, <p class="notification-list-item-body yf-9621vi">Higher clothing costs from tariffs are coming soon — but not immediately, experts say</p>, <p class="notification-list-item-body yf-9621vi">Why Tesla, GM, and Rivian will be hurt most by China's critical minerals export ban</p>, <p class="notification-list-item-body yf-9621vi">Trump says he's 'looking at something' to help car companies with tariffs</p>, <p class="notification-list-item-body yf-9621vi">Stocks rally for second straight day, while Apple jumps on tech tariff reprieve</p>, <p class="notification-list-item-body yf-9621vi">The Nasdaq briefly turned red as stocks' relief rally failed to hold in early afternoon trading</p>, <p class="notification-list-item-body yf-9621vi">Americans are braced for the biggest unemployment rate jump since the pandemic, a New York Fed survey found</p>, <p class="notification-list-item-body yf-9621vi">Stocks surge as Apple leads way higher after tech's tariff reprieve</p>, <p class="notification-list-item-body yf-9621vi">Trump's temporary tech tariff respite adds to a growing sense that he has a willingness to listen and bend</p>, <p class="notification-list-item-body yf-9621vi">Goldman CEO Solomon warns of 'markedly different operating environment' as dealmaking slows</p>, <p class="notification-list-item-body yf-9621vi">Corporate earnings take center stage amid tariff turmoil: What to know this week</p>, <p class="notification-list-item-body yf-9621vi">Trump has tariffs, taxes, and the debt ceiling on a collision course for this summer</p>, <p class="notification-list-item-body yf-9621vi">Trump denies that there was a tariff “exception” for certain electronics announced Friday. (Bloomberg)</p>, <p class="notification-list-item-body yf-9621vi">Tax day 2025 is coming up. Here’s what to know to file by the deadline.</p>, <p class="notification-list-item-body yf-9621vi">Commentary: Put the P/E ratio in timeout for now</p>, <p class="notification-list-item-body yf-9621vi">Market chaos signals 'sell America' trade as Trump tariff whipsaw threatens to upend the US economy's soft landing</p>, <p class="notification-list-item-body yf-9621vi">Apple was on brink of crisis before tariff concession from Trump (Bloomberg)</p>, <p class="notification-list-item-body yf-9621vi">Corporate earnings take center stage amid tariff turmoil: What to know this week</p>, <p class="notification-list-item-body yf-9621vi">The best (and worst) time of year to buy a house</p>, <p class="notification-list-item-body yf-9621vi">The Trump family is going all-in on crypto projects, from Bitcoin mining to stablecoins (Bloomberg)</p>, <p class="notification-list-item-body yf-9621vi">How to invest in gold in 4 steps</p>, <p class="notification-list-item-body yf-9621vi">Changing jobs can disrupt saving for retirement. Here's how to stay on track.</p>, <p class="notification-list-item-body yf-9621vi">Trump exempts phones, computers, chips from ‘reciprocal’ tariffs (Bloomberg)</p>, <p class="notification-list-item-body yf-9621vi">Meet Walmart heir Steuart Walton, the most powerful board member you’ve never heard of</p>, <p class="notification-list-item-body yf-9621vi">The tariff uncertainty isn't getting any better in markets: Chart of the Week</p>, <p class="notification-list-item-body yf-9621vi">'T-shirts could be the new eggs': Why Trump's chaotic tariff whipsaw is still a huge threat to inflation</p>, <p class="notification-list-item-body yf-9621vi">Gold notches best week since 2020 amid 'shaken' investor confidence in US</p>, <p class="notification-list-item-body yf-9621vi">The bond market just had one of its most volatile and unusual weeks in recent memory</p>, <p class="notification-list-item-body yf-9621vi">Stocks capped a wild week with a surge higher, as the S&amp;P 500 posted its biggest weekly gain since 2023</p>, <p class="notification-list-item-body yf-9621vi">Stocks swung into rally mode in afternoon trading, with the major indexes all up over 1%. Bond yields pared bigger gains.</p>, <p class="type-body-sm-med yf-rtg296">Unlock stock picks and a broker-level newsfeed that powers Wall Street.</p>, <p class="yf-1090901">We recently published a list of <strong><a class="link" data-rapid_p="13" data-ylk="slk:Biotech Stocks Dominate Monday’s Top 10 Gainers;elm:context_link;itc:0;sec:content-canvas" href="https://www.insidermonkey.com/blog/biotech-stocks-dominate-mondays-top-10-gainers-1507904/" rel="nofollow noopener" target="_blank">Biotech Stocks Dominate Monday’s Top 10 Gainers</a></strong>. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other biotech stocks that dominate Monday’s top gainers.</p>, <p class="yf-1090901">The stock market kicked off the shortened trading week on a positive note, with Wall Street’s major indices finishing in the green following President Donald Trump’s temporary tax reprieve on technology companies.</p>, <p class="yf-1090901">The S&amp;P 500 recorded the highest gain, up 0.79 percent, while the Dow Jones came second at 0.78 percent. The tech-heavy Nasdaq was also up by 0.64 percent.</p>, <p class="yf-1090901">Benchmark indices aside, 10 companies dominated by biotechnology firms mirrored the broader market optimism, recording modest gains during the session.</p>, <p class="yf-1090901">In this article, let us explore Monday’s top 10 gainers and the reasons behind their gains.</p>, <p class="yf-1090901">To come up with the list, we only considered the stocks with $2 billion market capitalization and $5 million trading volume.</p>, <p class="yf-1090901">A microbiologist in protective gear studying samples in a laboratory.</p>, <p class="yf-1090901">Viking Therapeutics Inc. saw its share prices jump by 10.58 percent on Monday to finish at $24.57 apiece following news that Pfizer Inc. (NYSE:PFE) will discontinue the development of its oral obesity medication, danuglipron, amid safety concerns.</p>, <p class="yf-1090901">According to PFE, the decision came after a patient experienced a potential liver injury linked to the drug.</p>, <p class="yf-1090901">The scrapped plans, however, spelled good news for VKTX which is similarly underway with the development of an oral weight loss candidate called VK2735, with PFE now out of the competition.</p>, <p class="yf-1090901">In other news, reports surfaced last month that PFE was set to take over VKTX, and tapped Morgan Stanley as its advisor for the acquisition.</p>, <p class="yf-1090901">The rumors came days after VKTX released its earnings performance in the fourth quarter of the year, widening its net loss by 44 percent to $35.4 million from the $24.6 million in the same period a year earlier.</p>, <p class="yf-1090901">Net loss for full-year 2024 also widened by 28 percent to $109.96 million from $85.895 million in 2023.</p>, <p class="yf-1090901">Overall, VKTX <strong><b>ranks 5th</b></strong> on our list of biotech stocks that dominate Monday’s top gainers. While we acknowledge the potential of VKTX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than VKTX but that trades at less than 5 times its earnings, check out our report about this <a class="link" data-rapid_p="14" data-ylk="slk:cheapest AI stock;elm:context_link;itc:0;sec:content-canvas" href="https://www.insidermonkey.com/blog/ai-fire-sale-insider-monkeys-1-ai-stock-pick-is-on-a-steep-discount-3/?forcedCTACode=PR4ST" rel="nofollow noopener" target="_blank"><b>cheapest AI stock</b></a>.</p>, <p class="yf-1090901"><strong><b>READ NEXT: </b></strong><a class="link" data-rapid_p="16" data-ylk="slk:20 Best AI Stocks To Buy Now;elm:context_link;itc:0;sec:content-canvas" href="https://www.insidermonkey.com/blog/20-best-artificial-intelligence-ai-stocks-to-buy-according-to-analysts-1424545/" rel="nofollow noopener" target="_blank"><strong><b>20 Best AI Stocks To Buy Now</b></strong></a><strong><b> and </b></strong><a class="link" data-rapid_p="17" data-ylk="slk:30 Best Stocks to Buy Now According to Billionaires;elm:context_link;itc:0;sec:content-canvas" href="https://www.insidermonkey.com/blog/30-best-stocks-to-invest-in-according-to-billionaires-1471371/" rel="nofollow noopener" target="_blank"><strong><b>30 Best Stocks to Buy Now According to Billionaires</b></strong></a>.</p>, <p class="yf-1090901">Disclosure: None. This article is originally published at <a class="link" data-rapid_p="18" data-ylk="slk:Insider Monkey;elm:context_link;itc:0;sec:content-canvas" href="https://www.insidermonkey.com/" rel="nofollow noopener" target="_blank"><strong><b>Insider Monkey</b></strong></a><strong><b>.</b></strong></p>, <p class="clamp yf-1y7058a">Shares of Novo Nordisk, Eli Lilly, Structure Therapeutics and Viking Therapeutics gain as PFE abandons development of its obesity candidate, danuglipron, due to safety issues.</p>, <p class="clamp yf-1y7058a">No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ: VKTX), the turbulence has been extremely challenging thus far.  The stock is down 71% over the past year, amid ongoing uncertainties regarding the timeline for future commercialization of its clinical pipeline and the broader stock market sell-off.  Progress toward regulatory approval with multiple data readouts expected later this year could be the catalyst for shares to rebound sharply.</p>, <p class="clamp yf-1y7058a">We recently published a list of Jim Cramer Sounds the Alarm on China Rhetoric and Dollar Panic Then Analyzes 11 Key Stocks. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other key stocks that Jim Cramer analyzes. In his latest appearance on CNBC’s Squawk on the […]</p>, <p class="clamp yf-1y7058a">CVS Health and UnitedHealth are two of the top companies leading the S&amp;P 500 chart YTD. But which is the better investment now? Let's take a closer look.</p>, <p class="clamp yf-1y7058a">Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to discontinue development of danuglipron, an oral glucagon-like peptide-1 receptor agonist, which was being investigated for chronic weight management. While Morgan Stanley predicts “limited reaction” in Pfizer’s shares following the news, JPMorgan tells investors that the decision is “mostly a positive” for Structure and Viking, both developing drugs in the</p>, <p class="clamp yf-1y7058a">With President Donald Trump announcing a wide set of tariffs, there could be increased costs for a range of companies.  Visa (NYSE: V) is a giant in the payments processing space, helping to ensure secure and convenient transactions between vendors and their customers.  The company boasts a solid track record of growing its revenue, net income, and free cash flow, as shown in the table below.</p>, <p class="clamp yf-1y7058a">When investing in crypto, it helps to look at the top performers to get a sense of what’s going on in the market.</p>, <p class="clamp yf-1y7058a">Here’s how inheriting an annuity works and what to do with it.</p>, <p class="clamp yf-1y7058a">It can be a smart strategy, provided you understand what you’re risking.</p>, <p class="clamp yf-1y7058a">Deciding between a $500,000 lump sum or $3,500 monthly annuity payments for your pension isn’t straightforward and involves weighing several personal factors. You need to consider how long you might live, which impacts how much total money you’ll get from monthly payments, alongside your retirement age to see how long your funds need to last. […] The post Should I Take a $500,000 Lump Sum or $3,500 Monthly Payments for My Pension? appeared first on SmartReads by SmartAsset.</p>, <p class="modules-module_tipMessage__ZQFev">Tip: Try a valid symbol or a specific company name for relevant results</p>, <p class="redirectMsg">Sign in to access your portfolio</p>, <p>
<span class="spcht" id="spcht"></span>
<span></span>
<span class="spcht" id="spcht-retry">Try again.</span>
</p>]